Gene promoter methylation is associated with lung function in the elderly: The normative aging study

Epigenetics

Volumn 7, Issue 3, 2012, Pages 261-269

  Lepeule, Johanna ^a   Baccarelli, Andrea ^a   Tarantini, Letizia ^b   Motta, Valeria ^a,b   Cantone, Laura ^b   Litonjua, Augusto A ^c   Sparrow, David ^d   Vokonas, Pantel S ^d   Schwartz, Joel ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA methylation; F3; GCR; Genes; INOS; Lungs; OGG1; Spirometry; TLR2

Indexed keywords

BLOOD CLOTTING FACTOR; CARNITINE ACETYLTRANSFERASE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2;

AGED; AGING; ARTICLE; BASOPHIL; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA METHYLATION; ELDERLY CARE; EOSINOPHIL; EPIGENETICS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC ASSOCIATION; HUMAN; LUNG FUNCTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MONOCYTE; NEGATIVE FEEDBACK; NEUTROPHIL COUNT; PROMOTER REGION; PROTEIN EXPRESSION; SMOKING; SPIROMETRY;

EID: 84858227674     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.7.3.19216     Document Type: Article

References (59)

1. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447:433-40; PMID:17522677; http://dx.doi.org/10.1038/nature05919.
2. Collas P, Noer A, Timoskainen S. Programming the genome in embryonic and somatic stem cells. J Cell Mol Med 2007; 11:602-20; PMID:17760828; http://dx.doi.org/10.1111/j.1582-4934.2007.00079.x.
3. Hirabayashi Y, Gotoh Y. Epigenetic control of neural precursor cell fate during development. Nat Rev Neurosci 2010; 11:377-88; PMID:20485363; http://dx.doi.org/10.1038/nrn2810.
4. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-86; PMID:19151715; http://dx.doi.org/10.1038/ng.298.
5. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 2004; 68:196-204; PMID:15180700; http://dx.doi.org/10.1046/j.1529-8817.2004.00081.x.
6. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148-59; PMID:18337604; http://dx.doi.org/10.1056/NEJMra072067.
7. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, Litonjua AA, et al. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 2011; 22:437-47; PMID:21188491; http://dx.doi.org/10.1007/s10552-010-9715-2.
8. Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003; 49:1292-6; PMID:12881445; http://dx.doi.org/10.1373/49.8.1292.
9. Shirodkar AV, Marsden PA. Epigenetics in cardiovascular disease. Curr Opin Cardiol 2011; 26:209-15; PMID:21415727; http://dx.doi.org/10.1097/HCO.0b013e328345986e.
10. Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet 2010; 3:567-73; PMID:21156932; http://dx.doi.org/10.1161/CIRCGENETICS.110.958744.
11. Fletcher C, Peto R, Tinker CM, Speizer FE. The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press 1976.
12. Rijcken B, Weiss ST. Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med 1996; 154:246-9; PMID:8970396.
13. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127:1952-9; PMID:15947307; http://dx.doi.org/10.1378/chest.127.6.1952.
14. Beaty TH, Cohen BH, Newill CA, Menkes HA, Diamond EL, Chen CJ. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 1982; 116:102-13; PMID:7102646.
15. Miller MR, Pedersen OF, Lange P, Vestbo J. Improved survival prediction from lung function data in a large population sample. Respir Med 2009; 103:442-8; PMID:18993043; http://dx.doi.org/10.1016/j.rmed.2008.09.016.
16. Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204-12; PMID:18166598; http://dx.doi.org/10.1183/09031936.00114307.
17. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006; 61:472-7; PMID:16517577; http://dx.doi.org/10.1136/thx.2005.052449.
18. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence and future trends. Lancet 2007; 370:765-73; PMID:17765526; http://dx.doi.org/10.1016/S0140-6736(07)61380-4.
19. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-504; PMID:9167458; http://dx.doi.org/10.1016/S0140-6736(96)07492-2.
20. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128:1995-2004; http://dx.doi.org/10.1378/chest.128.4.1995; PMID:16236847.
21. Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007; 62:515-20; http://dx.doi.org/10.1136/thx.2006.066969; PMID:17251312.
22. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006; 61:10-6; http://dx.doi.org/10.1136/thx.2004.034181; PMID:16284220.
23. Schünemann HJ, Muti P, Freudenheim JL, Armstrong D, Browne R, Klocke RA, et al. Oxidative stress and lung function. Am J Epidemiol 1997; 146:939-48; PMID:9400335.
24. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135:173-80; http://dx.doi.org/10.1378/chest.08-1419; PMID:19136405.
25. Bokarewa MI, Morrissey JH, Tarkowski A. Tissue factor as a proinflammatory agent. Arthritis Res 2002; 4:190-5; http://dx.doi.org/10.1186/ar405; PMID:12010569.
26. Vaidyula VR, Criner GJ, Grabianowski C, Rao AK. Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res 2009; 124:259-61; http://dx.doi.org/10.1016/j.thromres.2008.12.030; PMID:19162305.
27. Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9:883-9; PMID:7615158.
28. Nakamura S, Imamura T, Okamoto K. Tissue factor in neutrophils: yes. J Thromb Haemost 2004; 2:214-7; http://dx.doi.org/10.1111/j.1538-7836.2004.00548.x; PMID:14995980.
29. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007; 27:1687-93; http://dx.doi.org/10.1161/ATVBAHA.107.141911; PMID:17556654.
30. Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys 2005; 440:123-32; http://dx.doi.org/10.1016/j.abb.2005.06.005; PMID:16036212.
31. Haehnel V, Schwarzfischer L, Fenton MJ, Rehli M. Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J Immunol 2002; 168:5629-37; PMID:12023360.
32. Pons J, Sauleda J, Regueiro V, Santos C, López M, Ferrer J, et al. Expression of Toll-like receptor 2 is upregulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 2006; 7:64; http://dx.doi.org/10.1186/1465-9921-7-64; PMID:16606450.
33. Baines KJ, Simpson JL, Gibson PG. Innate immune responses are increased in chronic obstructive pulmonary disease. PLoS One 2011; 6:18426; http://dx.doi.org/10.1371/journal.pone.0018426; PMID:21483784.
34. Poole JA, Wyatt TA, Kielian T, Oldenburg P, Gleason AM, Bauer A, et al. Toll-like receptor 2 regulates organic dust-induced airway inflammation. Am J Respir Cell Mol Biol 2011; 45:711-9; http://dx.doi.org/10.1165/rcmb.2010-0427OC; PMID:21278324.
35. Chan GC, Fish JE, Mawji IA, Leung DD, Rachlis AC, Marsden PA. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol 2005; 175:3846-61; PMID:16148131.
36. Ricciardolo FL, Caramori G, Ito K, Capelli A, Brun P, Abatangelo G, et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol 2005; 116:1028-35; http://dx.doi.org/10.1016/j.jaci.2005.06.034; PMID:16275371.
37. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000; 162:701-6; PMID:10934109.
38. Brindicci C, Kharitonov SA, Ito M, Elliott MW, Hogg JC, Barnes PJ, et al. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181:21-30; http://dx.doi.org/10.1164/rccm.200904-0493OC; PMID:19797159.
39. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84:731-65; http://dx.doi.org/10.1152/physrev.00034.2003; PMID:15269335.
40. Alexeeff SE, Litonjua AA, Sparrow D, Vokonas PS, Schwartz J. Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 2007; 176:742-7; http://dx.doi.org/10.1164/rccm.200705-656OC; PMID:17673694.
41. Liu S, Li B, Zhou Y, Zhong N, Ran P. Genetic analysis of CC16, OGG1 and GCLC polymorphisms and susceptibility to COPD. Respirology 2007; 12:29-33; http://dx.doi.org/10.1111/j.1440-843.2006.00958.x; PMID:17207022.
42. Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, et al. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem 2009; 284:22840-52; http://dx.doi.org/10.1074/jbc.M109.032888; PMID:19553674.
43. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247:456-9; http://dx.doi.org/10.1126/science.1967851; PMID:1967851.
44. Melvin AJ, McGurn ME, Bort SJ, Gibson C, Lewis DB. Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells. Eur J Immunol 1995; 25:426-30; http://dx.doi.org/10.1002/eji.1830250218; PMID:7875204.
45. Mühl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 2003; 3:1247-55; http://dx.doi.org/10.1016/S1567-5769(03)00131-0; PMID:12890422.
46. Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferongamma. Mediators Inflamm 2001; 10:51-9; http://dx.doi.org/10.1080/09629350120054518; PMID:11405550.
47. Litonjua AA, Sparrow D, Guevarra L, O'Connor GT, Weiss ST, Tollerud DJ. Serum interferongamma is associated with longitudinal decline in lung function among asthmatic patients: the Normative Aging Study. Ann Allergy Asthma Immunol 2003; 90:422-8; http://dx.doi.org/10.1016/S1081-1206(10)61827-3; PMID:12722965.
48. Sin DD, Man SF. Interleukin-6: a red herring or a real catch in COPD? Chest 2008; 133:4-6; http://dx.doi.org/10.1378/chest.07-2085; PMID:18187736.
49. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149:1-38; http://dx.doi.org/10.1007/s10254-003-0012-2; PMID:12687404.
50. Madrigano J, Baccarelli A, Mittleman MA, Sparrow D, Vokonas PS, Tarantini L, et al. Aging and epigenetics: Longitudinal changes in gene-specific DNA methylation. Epigenetics 2012; 7: http://dx.doi.org/10.4161/epi.7.1.18749; PMID:22207354.
51. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008; 299:2877-83; http://dx.doi.org/10.1001/jama.299.24.2877; PMID:18577732.
52. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165-85; http://dx.doi.org/10.1183/09031936.00128008; PMID:19407051.
53. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 2010; 7:1000220; http://dx.doi.org/10.1371/journal.pmed.1000220; PMID:20305715.
54. Sin DD, Leung R, Gan WQ, Man SP. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007; 7:13; http://dx.doi.org/10.1186/1471-2466-7-13; PMID:17922919.
55. Bell B, Rose CL, Damon A. The Veterans Administration longitudinal study of healthy aging. Gerontologist 1966; 6:179-84; http://dx.doi.org/10.1093/geront/6.4.179; PMID:5342911.
56. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978; 118:1-120; PMID:742764.
57. Sparrow D, O'Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. The Normative Aging Study. Am Rev Respir Dis 1987; 135:1255-60; PMID:3296893.
58. AceView: integrative annotation of cDNA-supported genes in human, mouse, rat, worm and Arabidopsis.
59. Hernán MA, Lanoy E, Costagliola D, Robins JM. Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin Pharmacol Toxicol 2006; 98:237-42; http://dx.doi.org/10.1111/j.1742-7843.2006.pto_329.x; PMID:16611197.